Literature DB >> 18478199

An underlying principle for the study of circulating progenitor cells in diabetes and its complications.

G P Fadini1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18478199     DOI: 10.1007/s00125-008-1021-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  25 in total

Review 1.  Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation.

Authors:  Masataka Sata
Journal:  Trends Cardiovasc Med       Date:  2003-08       Impact factor: 6.677

2.  SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.

Authors:  Per M Humpert; Renate Neuwirth; Marco J Battista; Olga Voronko; Maximilian von Eynatten; Ilze Konrade; Gottfried Rudofsky; Thoralf Wendt; Andreas Hamann; Michael Morcos; Peter P Nawroth; Angelika Bierhaus
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

Review 3.  SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine?

Authors:  Andreas Schober; Ela Karshovska; Alma Zernecke; Christian Weber
Journal:  Trends Cardiovasc Med       Date:  2006-05       Impact factor: 6.677

Review 4.  Significance of endothelial progenitor cells in subjects with diabetes.

Authors:  Gian Paolo Fadini; Saverio Sartore; Carlo Agostini; Angelo Avogaro
Journal:  Diabetes Care       Date:  2007-02-02       Impact factor: 19.112

Review 5.  Endothelial progenitors: a new Tower of Babel?

Authors:  Jonathan Leor; Michael Marber
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

6.  Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?

Authors:  N A Hanley
Journal:  Diabetologia       Date:  2007-07-26       Impact factor: 10.122

7.  Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia.

Authors:  Alexandra Aicher; Markus Rentsch; Ken-ichiro Sasaki; Joachim W Ellwart; Fred Fändrich; Reiner Siebert; John P Cooke; Stefanie Dimmeler; Christopher Heeschen
Journal:  Circ Res       Date:  2007-02-01       Impact factor: 17.367

8.  Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling.

Authors:  Valentina Marchetti; Rossella Menghini; Stefano Rizza; Alessia Vivanti; Tiziana Feccia; Davide Lauro; Akiyoshi Fukamizu; Renato Lauro; Massimo Federici
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

9.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

10.  Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes.

Authors:  C G Egan; R Lavery; F Caporali; C Fondelli; F Laghi-Pasini; F Dotta; V Sorrentino
Journal:  Diabetologia       Date:  2008-02-20       Impact factor: 10.122

View more
  16 in total

Review 1.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

Review 2.  Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!

Authors:  C V Borlongan
Journal:  Leukemia       Date:  2011-07-05       Impact factor: 11.528

3.  Cord blood-circulating endothelial progenitors for treatment of vascular diseases.

Authors:  M Lavergne; V Vanneaux; C Delmau; E Gluckman; I Rodde-Astier; J Larghero; G Uzan
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Stem Cells for Neurovascular Repair in Stroke.

Authors:  Kazutaka Shinozuka; Travis Dailey; Naoki Tajiri; Hiroto Ishikawa; Dae Won Kim; Mibel Pabon; Sandra Acosta; Yuji Kaneko; Cesar V Borlongan
Journal:  J Stem Cell Res Ther       Date:  2013-05-01

Review 5.  The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.

Authors:  Cesar V Borlongan; Loren E Glover; Naoki Tajiri; Yuji Kaneko; Thomas B Freeman
Journal:  Prog Neurobiol       Date:  2011-08-30       Impact factor: 11.685

Review 6.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

7.  Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy.

Authors:  Kevin Tan; Emma Lessieur; Alecia Cutler; Patrice Nerone; Amit Vasanji; Kewal Asosingh; Serpil Erzurum; Bela Anand-Apte
Journal:  Exp Eye Res       Date:  2010-05-21       Impact factor: 3.467

Review 8.  Circulating stem cells and cardiovascular outcomes: from basic science to the clinic.

Authors:  Gian Paolo Fadini; Anurag Mehta; Devinder Singh Dhindsa; Benedetta Maria Bonora; Gopalkrishna Sreejit; Prabhakara Nagareddy; Arshed Ali Quyyumi
Journal:  Eur Heart J       Date:  2020-11-21       Impact factor: 29.983

9.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Diabetes mellitus induces bone marrow microangiopathy.

Authors:  Atsuhiko Oikawa; Mauro Siragusa; Federico Quaini; Giuseppe Mangialardi; Rajesh G Katare; Andrea Caporali; Jaap D van Buul; Floris P J van Alphen; Gallia Graiani; Gaia Spinetti; Nicolle Kraenkel; Lucia Prezioso; Costanza Emanueli; Paolo Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-30       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.